Dianthus Therapeutics, Inc. /DE/ (DNTH)

SEC filing

Dianthus Therapeutics, Inc. /DE/

DNTH · CIK 1690585

4 · Sep 3, 2026 · EVP, Head of R&D Randhawa Simrat sold 23.12K shares at $106.41/share ($2.5M); exercised options for 46.25K shares

EVP, Head of R&D Randhawa Simrat sold 23.12K shares at $106.41/share ($2.5M); exercised options for 46.25K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).